BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19734365)

  • 1. Adenylyl cyclase type 5 protein expression during cardiac development and stress.
    Hu CL; Chandra R; Ge H; Pain J; Yan L; Babu G; Depre C; Iwatsubo K; Ishikawa Y; Sadoshima J; Vatner SF; Vatner DE
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1776-82. PubMed ID: 19734365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.
    Okumura S; Takagi G; Kawabe J; Yang G; Lee MC; Hong C; Liu J; Vatner DE; Sadoshima J; Vatner SF; Ishikawa Y
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9986-90. PubMed ID: 12904575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload.
    Guellich A; Gao S; Hong C; Yan L; Wagner TE; Dhar SK; Ghaleh B; Hittinger L; Iwatsubo K; Ishikawa Y; Vatner SF; Vatner DE
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H707-12. PubMed ID: 20562336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.
    Vatner SF; Park M; Yan L; Lee GJ; Lai L; Iwatsubo K; Ishikawa Y; Pessin J; Vatner DE
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H1-8. PubMed ID: 23624627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout mice.
    Braeunig JH; Schweda F; Han PL; Seifert R
    PLoS One; 2013; 8(7):e68009. PubMed ID: 23840883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
    Yan L; Vatner SF; Vatner DE
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1521-8. PubMed ID: 25193472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation.
    Okumura S; Kawabe J; Yatani A; Takagi G; Lee MC; Hong C; Liu J; Takagi I; Sadoshima J; Vatner DE; Vatner SF; Ishikawa Y
    Circ Res; 2003 Aug; 93(4):364-71. PubMed ID: 12869393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes.
    Kapiloff MS; Piggott LA; Sadana R; Li J; Heredia LA; Henson E; Efendiev R; Dessauer CW
    J Biol Chem; 2009 Aug; 284(35):23540-6. PubMed ID: 19574217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.
    Lee KW; Hong JH; Choi IY; Che Y; Lee JK; Yang SD; Song CW; Kang HS; Lee JH; Noh JS; Shin HS; Han PL
    J Neurosci; 2002 Sep; 22(18):7931-40. PubMed ID: 12223546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
    Espinasse I; Iourgenko V; Richer C; Heimburger M; Defer N; Bourin MC; Samson F; Pussard E; Giudicelli JF; Michel JB; Hanoune J; Mercadier JJ
    Cardiovasc Res; 1999 Apr; 42(1):87-98. PubMed ID: 10434999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mouse heart adenylyl cyclase.
    Göttle M; Geduhn J; König B; Gille A; Höcherl K; Seifert R
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1156-65. PubMed ID: 19307450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6.
    Aldehni F; Tang T; Madsen K; Plattner M; Schreiber A; Friis UG; Hammond HK; Han PL; Schweda F
    Hypertension; 2011 Mar; 57(3):460-8. PubMed ID: 21282557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 5 adenylyl cyclase disruption leads to enhanced exercise performance.
    Vatner DE; Yan L; Lai L; Yuan C; Mouchiroud L; Pachon RE; Zhang J; Dillinger JG; Houtkooper RH; Auwerx J; Vatner SF
    Aging Cell; 2015 Dec; 14(6):1075-84. PubMed ID: 26424149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β
    Cosson MV; Hiis HG; Moltzau LR; Levy FO; Krobert KA
    J Mol Cell Cardiol; 2019 Jun; 131():132-145. PubMed ID: 31009605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase.
    Iwatsubo K; Bravo C; Uechi M; Baljinnyam E; Nakamura T; Umemura M; Lai L; Gao S; Yan L; Zhao X; Park M; Qiu H; Okumura S; Iwatsubo M; Vatner DE; Vatner SF; Ishikawa Y
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2622-8. PubMed ID: 22505646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase.
    Defer N; Best-Belpomme M; Hanoune J
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F400-16. PubMed ID: 10966920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy.
    Ulucan C; Wang X; Baljinnyam E; Bai Y; Okumura S; Sato M; Minamisawa S; Hirotani S; Ishikawa Y
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1662-72. PubMed ID: 17557924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway.
    Lai L; Yan L; Gao S; Hu CL; Ge H; Davidow A; Park M; Bravo C; Iwatsubo K; Ishikawa Y; Auwerx J; Sinclair DA; Vatner SF; Vatner DE
    Circulation; 2013 Apr; 127(16):1692-701. PubMed ID: 23536361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.
    Zhao Z; Babu GJ; Wen H; Fefelova N; Gordan R; Sui X; Yan L; Vatner DE; Vatner SF; Xie LH
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(3):H240-9. PubMed ID: 25485900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.